In addition to established efficacy for glycaemic control and weight loss, there has been growing enthusiasm surrounding the cardioprotective effects of GLP-1 agonists, as demonstrated from their superiority to placebo in multiple large studies in preventing major cardiovascular adverse events, namely reduced rates of myocardial infarcts, stroke, and rates of revascularisation procedures (Table 2)
The IGF-1 LR3 cell-culture application literature documents the molecules bioactivity at sub-nanomolar concentrations in human pluripotent stem-cell maintenance, hybridoma cell lines, CHO cell expression systems, and primary mammalian cell isolations [4]
When the exogenous GLP-1 signal is removed, the underlying drivers of weight gain return
Contact your healthcare provider promptly for: Suspected injection errors or technique concerns Persistent injection site reactions lasting more than 48 hours Gastrointestinal symptoms that interfere with eating, drinking, or medication adherence Blood glucose patterns that differ significantly from your usual readings Questions about whether to administer a replacement dose after injection error Call U.S
They also confirmed the lack of expression of GLP-1R in glial cells [4]